Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in RVMD held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | FARALLON CAPITAL MANAGEMENT LLC | 13.6M | $1.32B | -6.7% | 6.399% | 8.62% |
| 2 | BlackRock, Inc. | 11.2M | $1.09B | +25.6% | 5.274% | 0.02% |
| 3 | JANUS HENDERSON GROUP PLC | 9.8M | $949.5M | -20.6% | 4.594% | 0.47% |
| 4 | BAKER BROS. ADVISORS LP | 9.6M | $929.3M | +1.1% | 4.495% | 5.34% |
| 5 | FMR LLC | 8.5M | $823.2M | -1.4% | 3.981% | 0.04% |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | 8.4M | $813.2M | β | 3.933% | 0.02% |
| 7 | Nextech Invest, Ltd. | 7.6M | $739.2M | 0.0% | 3.575% | 52.02% |
| 8 | VANGUARD PORTFOLIO MANAGEMENT LLC | 7.5M | $729.6M | β | 3.529% | 0.04% |
| 9 | Paradigm Biocapital Advisors LP | 6.7M | $647.3M | +0.2% | 3.131% | 13.23% |
| 10 | WELLINGTON MANAGEMENT GROUP LLP | 6.0M | $586.2M | -13.7% | 2.835% | 0.11% |
| 11 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 5.5M | $532.5M | +148.3% | 2.576% | 0.82% |
| 12 | STATE STREET CORP | 4.4M | $428.2M | +7.1% | 2.071% | 0.01% |
| 13 | UBS Group AG | 4.4M | $427.3M | +42.3% | 2.067% | 0.06% |
| 14 | GEODE CAPITAL MANAGEMENT, LLC | 3.3M | $323.9M | +5.6% | 1.570% | 0.02% |
| 15 | Alphabet Inc. | 3.3M | $320.2M | -1.6% | 1.549% | 7.97% |
| 16 | BVF INC/IL | 2.9M | $277.8M | -14.9% | 1.344% | 8.85% |
| 17 | Casdin Capital, LLC | 2.6M | $250.6M | 0.0% | 1.212% | 18.98% |
| 18 | Woodline Partners LP | 2.5M | $243.8M | +0.2% | 1.179% | 0.92% |
| 19 | Holocene Advisors, LP | 2.5M | $240.1M | +29.4% | 1.161% | 0.58% |
| 20 | Vestal Point Capital, LP | 2.4M | $231.0M | +705.1% | 1.117% | 6.46% |
| 21 | Avoro Capital Advisors LLC | 2.3M | $228.0M | +8.0% | 1.103% | 2.33% |
| 22 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2.3M | $223.4M | -20.6% | 1.081% | 2.64% |
| 23 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 2.2M | $216.8M | +81.2% | 1.048% | 0.02% |
| 24 | GOLDMAN SACHS GROUP INC | 2.2M | $212.5M | -13.7% | 1.028% | 0.02% |
| 25 | Darwin Global Management, Ltd. | 2.2M | $205.0M | β | 1.040% | 5.44% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in RVMD β a direct measure of their conviction.
Filings activity in RVMD during Q1 2026, grouped by how each filer changed its position.
Institutions that opened a new RVMD position in Q1 2026
Institutions that fully closed their RVMD position in Q1 2026
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 494 | +30% | 56.90% | +10.25 pp | $18.61B | +22% |
| Q4 2025 | 381 | +22% | 46.65% | +20.71 pp | $15.26B | +80% |
| Q3 2025 | 313 | +3.3% | 25.94% | +5.61 pp | $8.48B | +28% |
| Q2 2025 | 303 | +8.2% | 20.33% | +0.55 pp | $6.65B | +2.8% |
| Q1 2025 | 280 | +1.1% | 19.78% | 5.00 pp | $6.47B | 20% |
| Q4 2024 | 277 | +11% | 24.78% | +2.42 pp | $8.11B | +11% |
| Q3 2024 | 249 | +13% | 22.36% | +3.10 pp | $7.31B | +16% |
| Q2 2024 | 220 | β | 19.26% | β | $6.30B | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying RVMD stock.
Based on Q1 2026 13F filings, institutional ownership of Revolution Medicines, Inc. stands at 56.9%, held across 494 reporting institutions.
FARALLON CAPITAL MANAGEMENT LLC is the largest reported institutional holder of RVMD, with approximately 13,604,796 shares worth $1.32B as of Q1 2026.
Yes β 1 widely-followed marquee investor appear among the top 25 institutional holders of RVMD, including SUSQUEHANNA INTERNATIONAL GROUP, LLP.
Our composite Smart Money Score for RVMD is 75 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
164 institutions opened new positions in RVMD during Q1 2026, while 51 fully exited. 259 added to existing positions and 70 trimmed.
RVMD institutional ownership rose by 10.25 percentage points quarter-over-quarter, with a net change of +113 holders.
The top 10 institutions account for 46.4% of all reported 13F value in RVMD, and the top 25 account for 69.8%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Revolution Medicines, Inc. (RVMD) Institutional Ownership